Related Experiment Video
Updated: Jul 17, 2026
09:09
Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients
Published on: April 3, 2026
Genetic markers in coronary heart disease
N S Kassem1, M M Mokhtar, M F Elbel-Bessy
1Human Genetics Department, Alexandria University, Medical Research Institute, Egypt.
The Journal of the Egyptian Public Health Association
|January 1, 1994
Summary
This study investigated genetic markers for coronary heart disease (CHD). Significant associations were found with specific lipoproteins and dermatoglyphics, suggesting a genetic predisposition for CHD.
Area of Science:
- Cardiovascular Genetics
- Human Genetics
Background:
- Coronary heart disease (CHD) exhibits familial aggregation.
- Understanding the genetic basis of CHD is crucial for risk assessment.
Purpose of the Study:
- To investigate associations between genetic markers and CHD.
- To identify potential genetic predisposition factors for CHD.
Main Methods:
- Compared genetic markers in 60 CHD patients and a control group.
- Analyzed lipoproteins, ABO blood groups, and dermatoglyphics (FTP, T-D count, palm patterns).
Main Results:
- Significant association of CHD with low alpha-lipoprotein and high pre-beta and beta-lipoproteins.
- Significant association of CHD with specific dermatoglyphics phenotypes (FTP, T-D count, palm patterns).
- No significant association found with ABO blood groups.
Conclusions:
- Genetic markers including lipoproteins and dermatoglyphics are significantly associated with CHD.
- These findings indicate a strong genetic etiology or predisposition for CHD.
- Identification of these markers can aid in identifying at-risk individuals for preventive genetic counseling.
Related Concept Videos
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:30Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...